RSV causes 43.7k severe respiratory cases annually in Brazil, with 82% affecting children under 2 years old, responsible for 75% of bronchiolitis cases. Pfizer's Abrysvo vaccine is administered as single dose to pregnant women from week 28, with potential to prevent approximately 28,000 hospitalizations yearly.
Brazil launches RSV vaccine distribution through public health system for pregnant women
Cobertura Relacionada
A marca Cisne vence pela quinta vez consecutiva a pesquisa Datafolha como melhor sal entre paulistanos, com 50% das menç…
Folha de S.Paulo · Aug 18 Projeto Quebrada Alimentada é eleito iniciativa de destaque em gastronomia pela FolhaO projeto Quebrada Alimentada, nascido no restaurante Mocotó durante a pandemia, foi eleito iniciativa de destaque pela …
UOL · Aug 17 Lucy Ramos revela que Globo consultou obstetra para cena de acidente na novelaA atriz Lucy Ramos revelou que a Globo consultou seu obstetra antes de gravar uma cena de acidente fatal enquanto ela es…
Estadão · Aug 17 Asma não impede atividade física; exercício regular ajuda no controle da doençaPesquisas confirmam que atividade física beneficia asmáticos, mas requer controle da doença e atenção a fatores ambienta…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
Brazil's public health system begins distributing Pfizer's RSV vaccine to pregnant women, strengthening maternal-child health infrastructure and establishing Brazil as a regional leader in preventive immunization.
Brazil demonstrates strategic autonomy in healthcare by integrating advanced vaccines into its universal health system (SUS), reducing dependence on private sector solutions and positioning itself as a model for developing nations. Pfizer gains market access and public health credibility in a major emerging economy.
Similar to Brazil's successful implementation of yellow fever and polio vaccination programs, this reflects the country's capacity to rapidly scale public health interventions across diverse populations.
Lente Económico
Brazil's public health system begins distributing Pfizer's RSV vaccine to pregnant women, potentially preventing ~28,000 annual hospitalizations and reducing healthcare costs while addressing a major respiratory threat to infants.
Pregnant women gain access to preventive healthcare at no direct cost through SUS; families with infants benefit from reduced hospitalization risk, lower out-of-pocket medical expenses, and improved child health outcomes; reduced burden on household budgets from RSV-related medical care.
Demonstrates government commitment to vaccine accessibility and preventive medicine integration into public systems; may encourage similar maternal immunization programs; potential model for other emerging vaccine adoption in developing economies; requires sustained funding allocation and supply chain management for SUS.